Lynx Global Digital Finance Corporation
Lynx Global Digital Finance Corporation CNONF Peers
See (CNONF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNONF | $0.04 | +389900.00% | 19.5B | -0.26 | -$0.15 | N/A |
| PMCUF | $176.00 | +0.13% | 18.4B | 283.87 | $0.62 | +0.11% |
| MTHRY | $6.94 | +2.66% | 9.4B | 33.05 | $0.21 | N/A |
| MTHRF | $12.98 | +0.23% | 8.8B | 31.66 | $0.41 | +0.01% |
| PANHF | $0.85 | N/A | 1.8B | 84.90 | $0.01 | +146.83% |
| BNVIF | $0.10 | +99900.00% | 1.7B | -0.16 | -$0.63 | N/A |
| CMPVF | $23.75 | -0.42% | 1.2B | 40.95 | $0.58 | +5.45% |
| PIAHY | $2.24 | -2.18% | 1.2B | 112.00 | $0.02 | +221.93% |
| CMPUY | $23.00 | N/A | 1.2B | 38.98 | $0.59 | N/A |
| CRWRF | $27.32 | N/A | 956.7M | 63.53 | $0.43 | +1.38% |
Stock Comparison
CNONF vs PMCUF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, PMCUF has a market cap of 18.4B. Regarding current trading prices, CNONF is priced at $0.04, while PMCUF trades at $176.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas PMCUF's P/E ratio is 283.87. In terms of profitability, CNONF's ROE is +1.60%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, CNONF is more volatile compared to PMCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MTHRY Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MTHRY has a market cap of 9.4B. Regarding current trading prices, CNONF is priced at $0.04, while MTHRY trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MTHRY's P/E ratio is 33.05. In terms of profitability, CNONF's ROE is +1.60%, compared to MTHRY's ROE of +0.09%. Regarding short-term risk, CNONF is more volatile compared to MTHRY. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MTHRF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MTHRF has a market cap of 8.8B. Regarding current trading prices, CNONF is priced at $0.04, while MTHRF trades at $12.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MTHRF's P/E ratio is 31.66. In terms of profitability, CNONF's ROE is +1.60%, compared to MTHRF's ROE of +0.09%. Regarding short-term risk, CNONF is more volatile compared to MTHRF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs PANHF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, PANHF has a market cap of 1.8B. Regarding current trading prices, CNONF is priced at $0.04, while PANHF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas PANHF's P/E ratio is 84.90. In terms of profitability, CNONF's ROE is +1.60%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, CNONF is more volatile compared to PANHF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs BNVIF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, BNVIF has a market cap of 1.7B. Regarding current trading prices, CNONF is priced at $0.04, while BNVIF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas BNVIF's P/E ratio is -0.16. In terms of profitability, CNONF's ROE is +1.60%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, CNONF is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for CNONF.
CNONF vs CMPVF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CMPVF has a market cap of 1.2B. Regarding current trading prices, CNONF is priced at $0.04, while CMPVF trades at $23.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CMPVF's P/E ratio is 40.95. In terms of profitability, CNONF's ROE is +1.60%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, CNONF is more volatile compared to CMPVF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs PIAHY Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, PIAHY has a market cap of 1.2B. Regarding current trading prices, CNONF is priced at $0.04, while PIAHY trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas PIAHY's P/E ratio is 112.00. In terms of profitability, CNONF's ROE is +1.60%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, CNONF is more volatile compared to PIAHY. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CMPUY Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, CNONF is priced at $0.04, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, CNONF's ROE is +1.60%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, CNONF is more volatile compared to CMPUY. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CRWRF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CRWRF has a market cap of 956.7M. Regarding current trading prices, CNONF is priced at $0.04, while CRWRF trades at $27.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CRWRF's P/E ratio is 63.53. In terms of profitability, CNONF's ROE is +1.60%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, CNONF is more volatile compared to CRWRF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs RSLBF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, RSLBF has a market cap of 822.8M. Regarding current trading prices, CNONF is priced at $0.04, while RSLBF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas RSLBF's P/E ratio is 35.29. In terms of profitability, CNONF's ROE is +1.60%, compared to RSLBF's ROE of +0.26%. Regarding short-term risk, CNONF is more volatile compared to RSLBF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs SUSRF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, SUSRF has a market cap of 790.9M. Regarding current trading prices, CNONF is priced at $0.04, while SUSRF trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas SUSRF's P/E ratio is 53.45. In terms of profitability, CNONF's ROE is +1.60%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, CNONF is more volatile compared to SUSRF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs SMSZF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, SMSZF has a market cap of 727.3M. Regarding current trading prices, CNONF is priced at $0.04, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas SMSZF's P/E ratio is 17.12. In terms of profitability, CNONF's ROE is +1.60%, compared to SMSZF's ROE of +0.20%. Regarding short-term risk, CNONF is more volatile compared to SMSZF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs RQHTF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, RQHTF has a market cap of 601.4M. Regarding current trading prices, CNONF is priced at $0.04, while RQHTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas RQHTF's P/E ratio is -2.00. In terms of profitability, CNONF's ROE is +1.60%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, CNONF is more volatile compared to RQHTF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs KSIOF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, KSIOF has a market cap of 441.8M. Regarding current trading prices, CNONF is priced at $0.04, while KSIOF trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas KSIOF's P/E ratio is -234.00. In terms of profitability, CNONF's ROE is +1.60%, compared to KSIOF's ROE of -0.05%. Regarding short-term risk, CNONF is more volatile compared to KSIOF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs VHIBF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, VHIBF has a market cap of 397.4M. Regarding current trading prices, CNONF is priced at $0.04, while VHIBF trades at $7.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas VHIBF's P/E ratio is 245.33. In terms of profitability, CNONF's ROE is +1.60%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, CNONF is more volatile compared to VHIBF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ONVVF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ONVVF has a market cap of 335.4M. Regarding current trading prices, CNONF is priced at $0.04, while ONVVF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ONVVF's P/E ratio is -20.00. In terms of profitability, CNONF's ROE is +1.60%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, CNONF is more volatile compared to ONVVF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs SMDCF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, CNONF is priced at $0.04, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, CNONF's ROE is +1.60%, compared to SMDCF's ROE of N/A. Regarding short-term risk, CNONF is more volatile compared to SMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs DLHTF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, CNONF is priced at $0.04, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, CNONF's ROE is +1.60%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, CNONF is more volatile compared to DLHTF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs VPAHF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, CNONF is priced at $0.04, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, CNONF's ROE is +1.60%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, CNONF is more volatile compared to VPAHF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs COGZF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, COGZF has a market cap of 146.8M. Regarding current trading prices, CNONF is priced at $0.04, while COGZF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas COGZF's P/E ratio is 21.75. In terms of profitability, CNONF's ROE is +1.60%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, CNONF is more volatile compared to COGZF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ACMLF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ACMLF has a market cap of 130.7M. Regarding current trading prices, CNONF is priced at $0.04, while ACMLF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ACMLF's P/E ratio is 30.33. In terms of profitability, CNONF's ROE is +1.60%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, CNONF is more volatile compared to ACMLF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CSAMF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, CNONF is priced at $0.04, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, CNONF's ROE is +1.60%, compared to CSAMF's ROE of -1.58%. Regarding short-term risk, CNONF is more volatile compared to CSAMF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs HSCHF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, HSCHF has a market cap of 95M. Regarding current trading prices, CNONF is priced at $0.04, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas HSCHF's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to HSCHF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MDPEF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MDPEF has a market cap of 85.8M. Regarding current trading prices, CNONF is priced at $0.04, while MDPEF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MDPEF's P/E ratio is 8.40. In terms of profitability, CNONF's ROE is +1.60%, compared to MDPEF's ROE of N/A. Regarding short-term risk, CNONF is more volatile compared to MDPEF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs FDBH Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, FDBH has a market cap of 82.1M. Regarding current trading prices, CNONF is priced at $0.04, while FDBH trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas FDBH's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, CNONF is more volatile compared to FDBH. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs HITC Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, CNONF is priced at $0.04, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas HITC's P/E ratio is -14.75. In terms of profitability, CNONF's ROE is +1.60%, compared to HITC's ROE of -1.29%. Regarding short-term risk, CNONF is more volatile compared to HITC. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs AHGIF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, AHGIF has a market cap of 27.3M. Regarding current trading prices, CNONF is priced at $0.04, while AHGIF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas AHGIF's P/E ratio is -1.52. In terms of profitability, CNONF's ROE is +1.60%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, CNONF is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for CNONF.
CNONF vs VASO Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, VASO has a market cap of 23.7M. Regarding current trading prices, CNONF is priced at $0.04, while VASO trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas VASO's P/E ratio is 13.50. In terms of profitability, CNONF's ROE is +1.60%, compared to VASO's ROE of +0.04%. Regarding short-term risk, CNONF is more volatile compared to VASO. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs RTNXF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, CNONF is priced at $0.04, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, CNONF's ROE is +1.60%, compared to RTNXF's ROE of +2.93%. Regarding short-term risk, CNONF is more volatile compared to RTNXF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs HDSLF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, CNONF is priced at $0.04, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, CNONF's ROE is +1.60%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, CNONF is more volatile compared to HDSLF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs THKKF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, CNONF is priced at $0.04, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas THKKF's P/E ratio is -1.51. In terms of profitability, CNONF's ROE is +1.60%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, CNONF is more volatile compared to THKKF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs DGNOF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, DGNOF has a market cap of 16.4M. Regarding current trading prices, CNONF is priced at $0.04, while DGNOF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas DGNOF's P/E ratio is -5.37. In terms of profitability, CNONF's ROE is +1.60%, compared to DGNOF's ROE of +2.18%. Regarding short-term risk, CNONF is more volatile compared to DGNOF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs TREIF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, TREIF has a market cap of 16.3M. Regarding current trading prices, CNONF is priced at $0.04, while TREIF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas TREIF's P/E ratio is -2.34. In terms of profitability, CNONF's ROE is +1.60%, compared to TREIF's ROE of -11.21%. Regarding short-term risk, CNONF is more volatile compared to TREIF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs RYAHF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, RYAHF has a market cap of 16M. Regarding current trading prices, CNONF is priced at $0.04, while RYAHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas RYAHF's P/E ratio is 0.81. In terms of profitability, CNONF's ROE is +1.60%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to RYAHF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs UDOCF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, UDOCF has a market cap of 14.5M. Regarding current trading prices, CNONF is priced at $0.04, while UDOCF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas UDOCF's P/E ratio is -3.17. In terms of profitability, CNONF's ROE is +1.60%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, CNONF is more volatile compared to UDOCF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MNNDF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, CNONF is priced at $0.04, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, CNONF's ROE is +1.60%, compared to MNNDF's ROE of N/A. Regarding short-term risk, CNONF is more volatile compared to MNNDF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs AIMLF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, AIMLF has a market cap of 14.2M. Regarding current trading prices, CNONF is priced at $0.04, while AIMLF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas AIMLF's P/E ratio is -2.04. In terms of profitability, CNONF's ROE is +1.60%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, CNONF is more volatile compared to AIMLF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CGNSF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CGNSF has a market cap of 12.3M. Regarding current trading prices, CNONF is priced at $0.04, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CGNSF's P/E ratio is -0.03. In terms of profitability, CNONF's ROE is +1.60%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, CNONF is more volatile compared to CGNSF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs PBSV Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, PBSV has a market cap of 11.5M. Regarding current trading prices, CNONF is priced at $0.04, while PBSV trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas PBSV's P/E ratio is -25.00. In terms of profitability, CNONF's ROE is +1.60%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, CNONF is more volatile compared to PBSV. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs SPLTF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, SPLTF has a market cap of 10.2M. Regarding current trading prices, CNONF is priced at $0.04, while SPLTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas SPLTF's P/E ratio is -3.33. In terms of profitability, CNONF's ROE is +1.60%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, CNONF is more volatile compared to SPLTF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs EMOR Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, EMOR has a market cap of 9.2M. Regarding current trading prices, CNONF is priced at $0.04, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas EMOR's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, CNONF is more volatile compared to EMOR. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs VYND Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, VYND has a market cap of 9.2M. Regarding current trading prices, CNONF is priced at $0.04, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas VYND's P/E ratio is -49.99. In terms of profitability, CNONF's ROE is +1.60%, compared to VYND's ROE of +0.48%. Regarding short-term risk, CNONF is more volatile compared to VYND. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CRVW Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CRVW has a market cap of 9.1M. Regarding current trading prices, CNONF is priced at $0.04, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CRVW's P/E ratio is -1.56. In terms of profitability, CNONF's ROE is +1.60%, compared to CRVW's ROE of +0.16%. Regarding short-term risk, CNONF is more volatile compared to CRVW. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs HBCNF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, CNONF is priced at $0.04, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, CNONF's ROE is +1.60%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, CNONF is more volatile compared to HBCNF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CRBKF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, CNONF is priced at $0.04, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, CNONF's ROE is +1.60%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, CNONF is more volatile compared to CRBKF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs TSTTF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, TSTTF has a market cap of 6.4M. Regarding current trading prices, CNONF is priced at $0.04, while TSTTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas TSTTF's P/E ratio is -2.50. In terms of profitability, CNONF's ROE is +1.60%, compared to TSTTF's ROE of +0.33%. Regarding short-term risk, CNONF is more volatile compared to TSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs DOCRF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, CNONF is priced at $0.04, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, CNONF's ROE is +1.60%, compared to DOCRF's ROE of -2.21%. Regarding short-term risk, CNONF is more volatile compared to DOCRF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CDXFF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CDXFF has a market cap of 5.5M. Regarding current trading prices, CNONF is priced at $0.04, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, CNONF's ROE is +1.60%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, CNONF is more volatile compared to CDXFF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CMPD Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CMPD has a market cap of 4.9M. Regarding current trading prices, CNONF is priced at $0.04, while CMPD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CMPD's P/E ratio is -14.32. In terms of profitability, CNONF's ROE is +1.60%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, CNONF is more volatile compared to CMPD. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CBDS Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CBDS has a market cap of 4.2M. Regarding current trading prices, CNONF is priced at $0.04, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CBDS's P/E ratio is -1.46. In terms of profitability, CNONF's ROE is +1.60%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, CNONF is more volatile compared to CBDS. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs IQAIF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, IQAIF has a market cap of 4.2M. Regarding current trading prices, CNONF is priced at $0.04, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas IQAIF's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to IQAIF's ROE of -1.62%. Regarding short-term risk, CNONF is more volatile compared to IQAIF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MDBIF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MDBIF has a market cap of 2.6M. Regarding current trading prices, CNONF is priced at $0.04, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MDBIF's P/E ratio is -0.14. In terms of profitability, CNONF's ROE is +1.60%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, CNONF is more volatile compared to MDBIF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MITI Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MITI has a market cap of 2.3M. Regarding current trading prices, CNONF is priced at $0.04, while MITI trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MITI's P/E ratio is -6.74. In terms of profitability, CNONF's ROE is +1.60%, compared to MITI's ROE of -0.05%. Regarding short-term risk, CNONF is more volatile compared to MITI. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CMHSF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CMHSF has a market cap of 2.2M. Regarding current trading prices, CNONF is priced at $0.04, while CMHSF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CMHSF's P/E ratio is 1.00. In terms of profitability, CNONF's ROE is +1.60%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, CNONF is more volatile compared to CMHSF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs EBYH Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, EBYH has a market cap of 2.1M. Regarding current trading prices, CNONF is priced at $0.04, while EBYH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas EBYH's P/E ratio is -6.00. In terms of profitability, CNONF's ROE is +1.60%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, CNONF is more volatile compared to EBYH. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs EKGGF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, EKGGF has a market cap of 1.9M. Regarding current trading prices, CNONF is priced at $0.04, while EKGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas EKGGF's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to EKGGF's ROE of +0.54%. Regarding short-term risk, CNONF is more volatile compared to EKGGF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ICCO Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ICCO has a market cap of 1.8M. Regarding current trading prices, CNONF is priced at $0.04, while ICCO trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ICCO's P/E ratio is -9.82. In terms of profitability, CNONF's ROE is +1.60%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, CNONF is more volatile compared to ICCO. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CSOC Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CSOC has a market cap of 1.5M. Regarding current trading prices, CNONF is priced at $0.04, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CSOC's P/E ratio is 0.26. In terms of profitability, CNONF's ROE is +1.60%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, CNONF is more volatile compared to CSOC. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs LVCE Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, LVCE has a market cap of 1.4M. Regarding current trading prices, CNONF is priced at $0.04, while LVCE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas LVCE's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to LVCE's ROE of N/A. Regarding short-term risk, CNONF is more volatile compared to LVCE. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs CTVEF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, CTVEF has a market cap of 1.2M. Regarding current trading prices, CNONF is priced at $0.04, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas CTVEF's P/E ratio is -0.23. In terms of profitability, CNONF's ROE is +1.60%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, CNONF is more volatile compared to CTVEF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs PPJE Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, PPJE has a market cap of 920.5K. Regarding current trading prices, CNONF is priced at $0.04, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas PPJE's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to PPJE. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MDXL Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MDXL has a market cap of 676K. Regarding current trading prices, CNONF is priced at $0.04, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MDXL's P/E ratio is -0.08. In terms of profitability, CNONF's ROE is +1.60%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, CNONF is more volatile compared to MDXL. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ACHKF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ACHKF has a market cap of 522.6K. Regarding current trading prices, CNONF is priced at $0.04, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ACHKF's P/E ratio is -0.07. In terms of profitability, CNONF's ROE is +1.60%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, CNONF is more volatile compared to ACHKF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MDNWF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, CNONF is priced at $0.04, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, CNONF's ROE is +1.60%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, CNONF is more volatile compared to MDNWF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MDRM Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MDRM has a market cap of 510.2K. Regarding current trading prices, CNONF is priced at $0.04, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MDRM's P/E ratio is -0.40. In terms of profitability, CNONF's ROE is +1.60%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, CNONF is more volatile compared to MDRM. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs NDATF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, NDATF has a market cap of 450.5K. Regarding current trading prices, CNONF is priced at $0.04, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas NDATF's P/E ratio is -0.55. In terms of profitability, CNONF's ROE is +1.60%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, CNONF is more volatile compared to NDATF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs EVAHF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, EVAHF has a market cap of 450K. Regarding current trading prices, CNONF is priced at $0.04, while EVAHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas EVAHF's P/E ratio is -3.60. In terms of profitability, CNONF's ROE is +1.60%, compared to EVAHF's ROE of +0.29%. Regarding short-term risk, CNONF is more volatile compared to EVAHF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs DTRK Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, DTRK has a market cap of 348K. Regarding current trading prices, CNONF is priced at $0.04, while DTRK trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas DTRK's P/E ratio is -5.45. In terms of profitability, CNONF's ROE is +1.60%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, CNONF is more volatile compared to DTRK. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs LFCOF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, LFCOF has a market cap of 313.3K. Regarding current trading prices, CNONF is priced at $0.04, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas LFCOF's P/E ratio is -0.05. In terms of profitability, CNONF's ROE is +1.60%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, CNONF is more volatile compared to LFCOF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs NEWUF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, NEWUF has a market cap of 190.6K. Regarding current trading prices, CNONF is priced at $0.04, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas NEWUF's P/E ratio is -0.04. In terms of profitability, CNONF's ROE is +1.60%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, CNONF is more volatile compared to NEWUF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs USPS Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, USPS has a market cap of 181.1K. Regarding current trading prices, CNONF is priced at $0.04, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas USPS's P/E ratio is -1.14. In terms of profitability, CNONF's ROE is +1.60%, compared to USPS's ROE of -0.63%. Regarding short-term risk, CNONF is more volatile compared to USPS. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ALDNF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, CNONF is priced at $0.04, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ALDNF's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to ALDNF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs EMYSF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, EMYSF has a market cap of 151.7K. Regarding current trading prices, CNONF is priced at $0.04, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas EMYSF's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to EMYSF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs NMXS Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, NMXS has a market cap of 116.8K. Regarding current trading prices, CNONF is priced at $0.04, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas NMXS's P/E ratio is -0.31. In terms of profitability, CNONF's ROE is +1.60%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, CNONF is more volatile compared to NMXS. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs DSOL Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, DSOL has a market cap of 88.9K. Regarding current trading prices, CNONF is priced at $0.04, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas DSOL's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, CNONF is more volatile compared to DSOL. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs NHIQ Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, NHIQ has a market cap of 85.2K. Regarding current trading prices, CNONF is priced at $0.04, while NHIQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas NHIQ's P/E ratio is -0.01. In terms of profitability, CNONF's ROE is +1.60%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, CNONF is more volatile compared to NHIQ. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs PASO Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, CNONF is priced at $0.04, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas PASO's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to PASO's ROE of +6.20%. Regarding short-term risk, CNONF is more volatile compared to PASO. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs REFG Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, CNONF is priced at $0.04, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas REFG's P/E ratio is -0.01. In terms of profitability, CNONF's ROE is +1.60%, compared to REFG's ROE of +0.01%. Regarding short-term risk, CNONF is more volatile compared to REFG. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs SOFE Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, CNONF is priced at $0.04, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas SOFE's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, CNONF is more volatile compared to SOFE. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs HDVY Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, CNONF is priced at $0.04, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas HDVY's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to HDVY. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs IGRW Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, CNONF is priced at $0.04, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas IGRW's P/E ratio is -0.00. In terms of profitability, CNONF's ROE is +1.60%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, CNONF is more volatile compared to IGRW. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs WMGR Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, CNONF is priced at $0.04, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas WMGR's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to WMGR. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs SSYNF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, CNONF is priced at $0.04, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, CNONF's ROE is +1.60%, compared to SSYNF's ROE of N/A. Regarding short-term risk, CNONF is more volatile compared to SSYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs RVRC Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, RVRC has a market cap of 31.4K. Regarding current trading prices, CNONF is priced at $0.04, while RVRC trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas RVRC's P/E ratio is -0.09. In terms of profitability, CNONF's ROE is +1.60%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, CNONF is more volatile compared to RVRC. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs TTBLF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, CNONF is priced at $0.04, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, CNONF's ROE is +1.60%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, CNONF is more volatile compared to TTBLF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ORHB Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ORHB has a market cap of 25.6K. Regarding current trading prices, CNONF is priced at $0.04, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ORHB's P/E ratio is -0.01. In terms of profitability, CNONF's ROE is +1.60%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, CNONF is more volatile compared to ORHB. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs EWLL Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, EWLL has a market cap of 18.5K. Regarding current trading prices, CNONF is priced at $0.04, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas EWLL's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to EWLL. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs NHEL Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, CNONF is priced at $0.04, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas NHEL's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to NHEL. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs PCYS Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, PCYS has a market cap of 11K. Regarding current trading prices, CNONF is priced at $0.04, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas PCYS's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, CNONF is more volatile compared to PCYS. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs HLTT Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, CNONF is priced at $0.04, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas HLTT's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, CNONF is more volatile compared to HLTT. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs OLMM Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, OLMM has a market cap of 10.1K. Regarding current trading prices, CNONF is priced at $0.04, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas OLMM's P/E ratio is -0.01. In terms of profitability, CNONF's ROE is +1.60%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to OLMM. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs MOSTQ Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, CNONF is priced at $0.04, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas MOSTQ's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, CNONF is more volatile compared to MOSTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs APYI Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, APYI has a market cap of 8.5K. Regarding current trading prices, CNONF is priced at $0.04, while APYI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas APYI's P/E ratio is -0.71. In terms of profitability, CNONF's ROE is +1.60%, compared to APYI's ROE of -0.60%. Regarding short-term risk, CNONF is more volatile compared to APYI. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ACNV Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, CNONF is priced at $0.04, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ACNV's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to ACNV. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs BBLNF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, CNONF is priced at $0.04, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas BBLNF's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, CNONF is more volatile compared to BBLNF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs ETAOF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, ETAOF has a market cap of 1.5K. Regarding current trading prices, CNONF is priced at $0.04, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas ETAOF's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, CNONF is more volatile compared to ETAOF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs LGBI Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, LGBI has a market cap of 5. Regarding current trading prices, CNONF is priced at $0.04, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas LGBI's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, CNONF is more volatile compared to LGBI. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs VMCS Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, VMCS has a market cap of 0. Regarding current trading prices, CNONF is priced at $0.04, while VMCS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas VMCS's P/E ratio is N/A. In terms of profitability, CNONF's ROE is +1.60%, compared to VMCS's ROE of +3.10%. Regarding short-term risk, CNONF is more volatile compared to VMCS. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.
CNONF vs WTEQF Comparison
CNONF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNONF stands at 19.5B. In comparison, WTEQF has a market cap of 0. Regarding current trading prices, CNONF is priced at $0.04, while WTEQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNONF currently has a P/E ratio of -0.26, whereas WTEQF's P/E ratio is 1.78. In terms of profitability, CNONF's ROE is +1.60%, compared to WTEQF's ROE of N/A. Regarding short-term risk, CNONF is more volatile compared to WTEQF. This indicates potentially higher risk in terms of short-term price fluctuations for CNONF.